209 related articles for article (PubMed ID: 24395524)
21.
Vahdatinia M; Derakhshan F; Da Cruz Paula A; Dopeso H; Marra A; Gazzo AM; Brown D; Selenica P; Ross DS; Razavi P; Zhang H; Weigelt B; Wen HY; Brogi E; Reis-Filho JS; Pareja F
J Clin Pathol; 2023 Dec; 77(1):40-45. PubMed ID: 36323507
[TBL] [Abstract][Full Text] [Related]
22. The landscape of cancer genes and mutational processes in breast cancer.
Stephens PJ; Tarpey PS; Davies H; Van Loo P; Greenman C; Wedge DC; Nik-Zainal S; Martin S; Varela I; Bignell GR; Yates LR; Papaemmanuil E; Beare D; Butler A; Cheverton A; Gamble J; Hinton J; Jia M; Jayakumar A; Jones D; Latimer C; Lau KW; McLaren S; McBride DJ; Menzies A; Mudie L; Raine K; Rad R; Chapman MS; Teague J; Easton D; Langerød A; ; Lee MT; Shen CY; Tee BT; Huimin BW; Broeks A; Vargas AC; Turashvili G; Martens J; Fatima A; Miron P; Chin SF; Thomas G; Boyault S; Mariani O; Lakhani SR; van de Vijver M; van 't Veer L; Foekens J; Desmedt C; Sotiriou C; Tutt A; Caldas C; Reis-Filho JS; Aparicio SA; Salomon AV; Børresen-Dale AL; Richardson AL; Campbell PJ; Futreal PA; Stratton MR
Nature; 2012 May; 486(7403):400-4. PubMed ID: 22722201
[TBL] [Abstract][Full Text] [Related]
23. Histologic and genomic characterization of a primary mucinous carcinoma of the skin.
Papanastasiou AD; De Filippo MR; Sirinian C; Selenica P; Repanti M; Reis-Filho JS; Weigelt B
EJC Skin Cancer; 2023; 1():. PubMed ID: 38274496
[TBL] [Abstract][Full Text] [Related]
24. Pan-Cancer Analysis Reveals the Diverse Landscape of Novel Sense and Antisense Fusion Transcripts.
Vellichirammal NN; Albahrani A; Banwait JK; Mishra NK; Li Y; Roychoudhury S; Kling MJ; Mirza S; Bhakat KK; Band V; Joshi SS; Guda C
Mol Ther Nucleic Acids; 2020 Mar; 19():1379-1398. PubMed ID: 32160708
[TBL] [Abstract][Full Text] [Related]
25. The diverse heterogeneity of molecular alterations in prostate cancer identified through next-generation sequencing.
Wyatt AW; Mo F; Wang Y; Collins CC
Asian J Androl; 2013 May; 15(3):301-8. PubMed ID: 23503423
[TBL] [Abstract][Full Text] [Related]
26. Divide and conquer: the genetic basis of molecular subclassification of breast cancer.
Kristensen VN
EMBO Mol Med; 2011 Apr; 3(4):183-5. PubMed ID: 21394915
[TBL] [Abstract][Full Text] [Related]
27. Pan-Cancer Drivers Are Recurrent Transcriptional Regulatory Heterogeneities in Early-Stage Luminal Breast Cancer.
Singh S; Sutcliffe MD; Repich K; Atkins KA; Harvey JA; Janes KA
Cancer Res; 2021 Apr; 81(7):1840-1852. PubMed ID: 33531373
[TBL] [Abstract][Full Text] [Related]
28. Interchromosomal Translocations as a Means to Map Chromosome Territories in Breast Cancer.
Parl FF; Dupont WD; Crooke PS
Cancer Inform; 2019; 18():1176935119842573. PubMed ID: 31019364
[TBL] [Abstract][Full Text] [Related]
29. Case report: A rare case of dual primary synchronous malignancies of the breast and kidney in a 70 year female.
Hamid T; Khan F; Khattak NS; Kakakhel MNA; Hamid R
Int J Surg Case Rep; 2024 Mar; 116():109400. PubMed ID: 38368668
[TBL] [Abstract][Full Text] [Related]
30. Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers.
Paratala BS; Dolfi SC; Khiabanian H; Rodriguez-Rodriguez L; Ganesan S; Hirshfield KM
Biomark Cancer; 2016; 8(Supple 1):1-14. PubMed ID: 26917980
[TBL] [Abstract][Full Text] [Related]
31. Drug repositioning in thyroid cancer: from point mutations to gene fusions.
Sánchez-Marín D; Silva-Cázares MB; González-Del Carmen M; Campos-Parra AD
Front Oncol; 2024; 14():1407511. PubMed ID: 38779099
[TBL] [Abstract][Full Text] [Related]
32. Genetics 101: detecting mutations in human genes.
Sinclair A
CMAJ; 2002 Aug; 167(3):275-9. PubMed ID: 12186176
[No Abstract] [Full Text] [Related]
33. FusionNW, a potential clinical impact assessment of kinases in pan-cancer fusion gene network.
Yang C; Kumar H; Kim P
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38493341
[TBL] [Abstract][Full Text] [Related]
34. Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors.
Joshi PM; Sutor SL; Huntoon CJ; Karnitz LM
J Biol Chem; 2014 Mar; 289(13):9247-53. PubMed ID: 24554720
[TBL] [Abstract][Full Text] [Related]
35. SF3B1 mutations constitute a novel therapeutic target in breast cancer.
Maguire SL; Leonidou A; Wai P; Marchiò C; Ng CK; Sapino A; Salomon AV; Reis-Filho JS; Weigelt B; Natrajan RC
J Pathol; 2015 Mar; 235(4):571-80. PubMed ID: 25424858
[TBL] [Abstract][Full Text] [Related]
36. CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer.
Johnson SF; Cruz C; Greifenberg AK; Dust S; Stover DG; Chi D; Primack B; Cao S; Bernhardy AJ; Coulson R; Lazaro JB; Kochupurakkal B; Sun H; Unitt C; Moreau LA; Sarosiek KA; Scaltriti M; Juric D; Baselga J; Richardson AL; Rodig SJ; D'Andrea AD; Balmaña J; Johnson N; Geyer M; Serra V; Lim E; Shapiro GI
Cell Rep; 2016 Nov; 17(9):2367-2381. PubMed ID: 27880910
[TBL] [Abstract][Full Text] [Related]
37. Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected].
Weigelt B; Ng CK; Shen R; Popova T; Schizas M; Natrajan R; Mariani O; Stern MH; Norton L; Vincent-Salomon A; Reis-Filho JS
Mod Pathol; 2015 Mar; 28(3):340-51. PubMed ID: 25412848
[TBL] [Abstract][Full Text] [Related]
38. Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast.
Piscuoglio S; Ng CK; Martelotto LG; Eberle CA; Cowell CF; Natrajan R; Bidard FC; De Mattos-Arruda L; Wilkerson PM; Mariani O; Vincent-Salomon A; Weigelt B; Reis-Filho JS
Mol Oncol; 2014 Dec; 8(8):1588-602. PubMed ID: 25041824
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer.
Naidoo K; Wai PT; Maguire SL; Daley F; Haider S; Kriplani D; Campbell J; Mirza H; Grigoriadis A; Tutt A; Moseley PM; Abdel-Fatah TMA; Chan SYT; Madhusudan S; Rhaka EA; Ellis IO; Lord CJ; Yuan Y; Green AR; Natrajan R
Mol Cancer Ther; 2018 Jan; 17(1):306-315. PubMed ID: 29133620
[TBL] [Abstract][Full Text] [Related]
40. Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification.
Ng CK; Martelotto LG; Gauthier A; Wen HC; Piscuoglio S; Lim RS; Cowell CF; Wilkerson PM; Wai P; Rodrigues DN; Arnould L; Geyer FC; Bromberg SE; Lacroix-Triki M; Penault-Llorca F; Giard S; Sastre-Garau X; Natrajan R; Norton L; Cottu PH; Weigelt B; Vincent-Salomon A; Reis-Filho JS
Genome Biol; 2015 May; 16(1):107. PubMed ID: 25994018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
